Treatment and services

ADDITIONAL RESOURCES

FROM THE TASK FORCE

Addressing the Larger Mental Health Context of Opioid Use and Misuse: Suicide and the Opioid Epidemic

Screening and Assessment

Screening and Assessment Tools (American Society of Addiction Medicine-ASAM)

Screening and Assessment of Co-occurring Disorders in the Justice System (SAMHSA)

TIP 31: Screening and Assessing Adolescents for Substance Use Disorders (6/2012, SAMHSA): Guidelines in screening and assessing teens for substance use conditions.

Addiction Severity Index, Fifth Edition (Thomas McLellan, Ph.D.; Deni Carise, Ph.D.; Thomas H. Coyne, MSW; T. Ron Jackson, MSW)

Forms (Texas Christian University Institute of Behavioral Research)

GAIN Instruments (Global Appraisal of Individual Needs-GAIN))

TCU Drug Screen 5 (2017, TCU Institute of Behavioral Research)

TCU Drug Screen 5 - Opioid Supplement (9/2017, TCU Institute of Behavioral Research)

Opioid Risk Tool (National Institute on Drug Abuse)

Medication Assisted Treatment

Treatment of Opioid Use Disorder (9/2018, NJOTF): Discusses key issues surrounding medication assisted treatment (MAT), the evidence that underlies treatment types for opioid use disorder, best practices, and legal implications.

Medication for Substance Use Disorders (4/2024, SAMHSA)

Treatment (1/2023, National Institute on Drug Abuse)

Medications to Treat Opioid Use Disorder Research Report: How is opioid use disorder treated in the criminal justice system? (12/2021, National Institute on Drug Abuse): Useful to start a discussion on the current state of treatment.

Medication-assisted treatment for youth with opioid use disorder: Current dilemmas and remaining questions (2018, The American Journal of Drug and Alcohol Abuse)

Medication-Assisted Treatment for Adolescents in Specialty Treatment for Opioid Use Disorder (6/2017, Journal of Adolescent Health)

Medication-Assisted Treatment of Adolescents with Opioid Use Disorders (9/2016, Pediatrics, American Academy of Pediatrics Committee on Substance Use and Prevention)

Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition) (1/2018, National Institute on Drug Abuse)

Providers Clinical Support System - Medications for Opioid Use Disorders (PCSS-MOUD) (SAMHSA)

Behavioral Health Treatment Services Locator (SAMHSA)

The Case for Medication-Assisted Treatment: MAT can help people with opioid use disorders, but few have access (1/2017, The Pew Charitable Trusts)

Medication-Assisted Treatment Improves Outcomes for Patients With Opioid Use Disorder (11/2016, The Pew Charitable Trusts)

Naloxone in Correctional Facilities for the Prevention of Opioid Overdose Deaths (2020) (National Commission on Correctional Health Care)

Medication Assisted Treatment Studies

Drug Trials Snapshot: LUCEMYRA (5/2018, U.S. Food and Drug Administration)

Relapse to opioid use disorder after inpatient treatment: Protective effect of injection naltrexone. (2/2018, Nunes EV, et al.)

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial. (1/2018, Lee JD, et al.)

Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial. (4/2016, Hser YI, et al.)

Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study. (5/2015, Weiss RD, et al.)

Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial. (1/2014, Hser YI, et al.)

Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.(12/2011, Weiss RD, et al.)

Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial. (4/2011, Krupitsky E, et al.)

Treatment of Substance Use Disorder (SUD)

The ASAM Criteria (American Society of Addiction Medicine)

Patient Resources (American Society of Addiction Medicine): Dynamic patient resource guide to addiction.

Finding Quality Treatment for Substance Use Disorders (4/2018, Substance Abuse and Mental Health Services Administration SAMHSA)

Treatment (1/2023, National Institute on Drug Abuse)

Substance Use Publications and Digital Products (SAMHSA)

National Center for Trauma-Informed Care (NCTIC) (SAMHSA)

Program Profile: Interim Methadone Maintenance (IM) (6/2011, National Institute of Justice)

Brief Interventions and Brief Therapies for Substance Abuse (1999, SAMHSA): Brief intervention and therapy techniques for the treatment of alcohol and drug misuse.

Medication Assisted Treatment of Opioid Use Disorder (OUD)

Naloxone Use in the Courthouse – A Judicial Bench Card (4/2019, NJOTF): Describes the signs of overdose, what to do if one occurs, how naloxone can be used to reverse the toxic effects of an overdose, and suggestions for a naloxone policy.

Naloxone Awareness Campaign (10/2022, Addiction Policy Forum)

Medications to Treat Opioid Use Disorder: Overview (12/2021, National Institute on Drug Abuse)

Opioid Overdose Prevention Toolkit (1/2024, SAMHSA)

Naloxone DrugFacts (1/2022, National Institute on Drug Abuse)

TIP 63: Medications for Opioid Use Disorder – Full Document (7/2021, SAMHSA)

Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings (2019, SAHMSA)

ASAM National Practice Guideline for the Treatment of Opioid Use Disorder (2020, American Society of Addiction Medicine)

Federal Guidelines for Opioid Treatment Programs (3/2015, SAMHSA)

Clinical Use of Extended-Release Injectable Naltrexone in the Treatment of Opioid Use Disorder: A Brief Guide (12/2014, SAMHSA)

MAT in Drug Courts: Recommended Strategies (2016, Legal Action Center)

Adult Drug Courts and Medication Assisted Treatment for Opioid Dependence (9/2014, SAMHSA)

Program Profile: Buprenorphine Maintenance Treatment (2019, National Institute of Justice)